Novo Nordisk is shaking up its executive team as it bids adieu to its longtime head of commercial strategy and corporate ...

Novo Nordisk (NVO) said Thursday Camilla Sylvest has decided to leave the company, after a distinguished career of 28 years with the drugmaker, seven years as executive vice president of commercial ...

Novo Nordisk (NVO) executive Camilla Sylvest is departing the drugmaker after 28 years, Bloomberg’s Sara Sjolin reports. Sylvest has served as ...

Camilla Sylvest’s caution is possibly to be expected from an executive of a company that, until mid-2022, was known only for its critical but unspectacular business as a maker of insulin and ...

Novo Nordisk has announced major leadership changes, with EVP Camilla Sylvest departing and Ludovic Helfgott taking on an expanded role.

After a distinguished career of 28 years with Novo Nordisk, hereof seven years as executive vice president of Commercial Strategy & Corporate Affairs, Camilla Sylvest has decided to leave the company.

Camilla Sylvest, Novo Nordisk's head of commercial strategy and corporate affairs, said at the company's Capital Markets Day yesterday that the company expects to meet demand for Wegovy in the US ...

Novo Nordisk (NVO) said Thursday Camilla Sylvest has decided to leave the company, after a distinguished career of 28 years with the drugmaker, seven years as executive vice president of ...